about
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaNerve cell damage in mammalian brain after exposure to microwaves from GSM mobile phonesMolecular genetic characterisation of frontotemporal dementia on chromosome 3Regional differences in the proton magnetic resonance relaxation times T1 and T2 within the normal human brain.Radiofrequency and extremely low-frequency electromagnetic field effects on the blood-brain barrier.Blood-brain barrier permeability and nerve cell damage in rat brain 14 and 28 days after exposure to microwaves from GSM mobile phones.A factor analytic approach to symptom patterns in dementia.Increased blood-brain barrier permeability in mammalian brain 7 days after exposure to the radiation from a GSM-900 mobile phone.The birth and early evolution of the frontotemporal dementia (FTD) concept.White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments.Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias.Fundamental pathological lesions in vascular dementia.The RG2 rat glioma model.The accuracy of short clinical rating scales in neuropathologically diagnosed dementia.Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden.Synapse density related to cerebral blood flow and symptomatology in frontal lobe degeneration and Alzheimer's disease.Neutron capture imaging of 10B in tissue specimens.Genetic characterization of a familial non-specific dementia originating in Jutland, Denmark.A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.Metoclopramide as a sensitizer of 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of brain tumors in the rat.Clinical manifestations in neuropathologically defined subgroups of vascular dementia.Contributions of other brain pathologies in dementia with lewy bodies.Histopathological examinations of rat brains after long-term exposure to GSM-900 mobile phone radiation.A clinico-pathological study of heart and brain lesions in vascular dementia.Hydra head activator-like immunoreactivity in human brain astrocytomas grade III-IV and the surrounding brain tissue.Necrosis of malignant gliomas after intratumoral injection of 201Tl in vivo in the rat.Cognitive impairment in rats after long-term exposure to GSM-900 mobile phone radiation.White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates.Magnetic resonance imaging and histopathology in dementia, clinically of frontotemporal type.Regional cerebral blood flow and EEG in clinically diagnosed dementia with Lewy bodies and Alzheimer's disease.DOES DOWN SYNDROME SUPPORT HOMOCYSTEINE THEORY OF ARTERIOSCLEROSIS?Genetic characterization of a novel familial dementiaA stochastic model for subcellular dosimetry in boron neutron capture therapyGrowth inhibition of rat glioma cells in vitro and in vivo by aspirinMisclassification of dementia subtype using the Hachinski Ischemic Score: results of a meta-analysis of patients with pathologically verified dementiasNeuropathological correlates to clinically defined dementia with Lewy bodies
P50
Q24309521-73A2FBFD-177A-4A3C-A8A1-D555EBDF167CQ24530057-FB921294-86B6-4AA2-91D8-C0DC9A0304F8Q28141390-C15F7435-FE5A-469E-AA82-630E71B7BE50Q30696581-F0DB680E-0885-46FD-9B06-1E4E8B9DBDD1Q34012377-4A3B2382-ED0F-4655-A9A8-908F60B840BEQ34013924-0410680F-8F22-4124-8E32-073973EC8330Q34495325-E7108ADA-C474-46FB-833A-5A5274B44F8DQ37432711-946FEB56-F228-4527-8C2F-6A95A7F97031Q37885814-C07371AB-7E5F-4999-8835-653DADB06B45Q41233743-EAEE02CC-79B7-4A83-A853-4511D9C2B6A6Q41315937-8E13BA6D-1A38-4286-8A81-D0B729B5A305Q41315951-8129F8FA-E964-405E-B1A6-84EBFD846B3DQ41398023-123E3D9F-3ED7-4C20-B9EC-64FB0C6F546DQ43429441-DA233F31-542D-4B2B-AD6C-4934E0475515Q44442723-FAF73F2F-8F34-436D-B00E-8CE1BC1E171CQ48143168-56BAD42A-0649-4924-86BB-6C6A18CF0282Q48334869-C05F64CE-7C1C-47A4-B4C2-D749783B6FAFQ48337250-586D19AE-A574-4E8C-97CD-578B711AAACBQ48367859-1CA7A988-19EC-4035-88A7-034E55521406Q48474527-FC379A94-AFE5-4EDC-8FB0-C9DD64AD7ABFQ48478965-6081581E-2D7E-4D52-B2B3-D4D54E25DE34Q48662171-3AC25A44-C2CE-4813-B3AF-F2B41CBACD54Q48931711-B068FE77-4B08-4E95-ADAD-8F130F17A80BQ49073699-9D4303DD-5E19-4162-99F2-088D406AEFDBQ49082883-BC0D517F-1FE0-452E-AA31-C39EA74690A2Q51611727-5F2AFF86-1E41-4DBD-90CA-F744ABC072D7Q51969311-172C251B-76D7-438F-BA1A-A053A156366BQ53191831-72E0AFF0-9D7C-4B98-87A6-595BF0A30E3DQ53234296-4381B4D0-4447-4606-9541-6DE4D7F5D179Q53255334-24C24407-3382-4016-9FE6-106638BD25B9Q60597027-C28D5714-0053-4880-9654-4BF3FD0DD65CQ67831690-63508C9A-F13E-44B2-9CD2-5C0B92DE5C55Q70967983-24175764-4851-4319-87D9-7E2DC56C8280Q71749095-6938CFB0-1D0E-4CD7-804B-DB1C630C8831Q73786427-EF46F682-B8DE-49FA-AB38-CB86CD5F6719Q74245351-BFD06AA8-3E94-416D-8B35-63C42E935602
P50
description
forsker
@nb
neuropathologist
@en
neuropatholoog
@nl
name
Arne Brun
@ast
Arne Brun
@en
Arne Brun
@es
Arne Brun
@nb
Arne Brun
@nl
type
label
Arne Brun
@ast
Arne Brun
@en
Arne Brun
@es
Arne Brun
@nb
Arne Brun
@nl
altLabel
Arne E. Brun
@en
Arne E. Brun
@nb
prefLabel
Arne Brun
@ast
Arne Brun
@en
Arne Brun
@es
Arne Brun
@nb
Arne Brun
@nl
P1006
P214
P244
P906
P1006
P106
P108
P1153
35403799900
P21
P214
P244
no2011080381
P31
P569
1930-01-01T00:00:00Z
P734
P7859
lccn-no2011080381